BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Knorr J, Tuttle JL, Sabo JA, East DH, Price KL, Shen L. Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2). Trials 2021;22:726. [PMID: 34674750 DOI: 10.1186/s13063-021-05699-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Gettman L. New Drugs Update: Three Novel Treatments for SARS-CoV-2. sr care pharm 2022;37:317-328. [DOI: 10.4140/tcp.n.2022.317] [Reference Citation Analysis]
2 Hirsch C, Park YS, Piechotta V, Chai KL, Estcourt LJ, Monsef I, Salomon S, Wood EM, So-Osman C, McQuilten Z, Spinner CD, Malin JJ, Stegemann M, Skoetz N, Kreuzberger N. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. Cochrane Database Syst Rev 2022;6:CD014945. [PMID: 35713300 DOI: 10.1002/14651858.CD014945.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]